IMPACT Therapeutics, Inc

HK$9.03As of Sun 8 Nov 2026, 12:00 UTC
HKEX:7630Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Drug Manufacturers (General)
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap HK$2.551B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$10
13.00%
(50.65%)
Hold 0|9|9|9|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.10
0.10
0.09
0.09
17.82%
9.45%
(2.65%)
(11.66%)
Revenue¥M
125.6
121.9
118.5
120.5
1.77%
(0.39%)
(2.63%)
(4.15%)
Peers (US$325.4M)
Cap (US$)
PE
326.9M
189.3x
Capital
TTM
5Y
10Y
Leveragex
0.380
—
(0.016)
EBIT/Intx
0.804
4.504
3.473
Own earn%
52.16
141.43
100.66
Sh yield%
13.03
23.56
22.33
Owners
Insiders/Inst%
12.41
60.04
Short interest%
5.95
SBC / revenue%
3.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
17–26
$1 testx
—
Incr. ROIC%
−1